Retatrutide Research Supplier — UK
Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not intended for human consumption, therapeutic use, or clinical application. All purchases must comply with applicable local laws and regulations.
Aarise Healthcare exports Retatrutide (CAS: 2381247-90-9) to research institutions in UK. Our WHO-GMP certified facility in India supplies 98%+ purity Retatrutide for triple GIP/GLP-1/glucagon receptor research.
Retatrutide Export Specifications for UK
| Compound | Retatrutide |
| CAS Number | 2381247-90-9 |
| Purity | 98%+ (HPLC verified) |
| Form | Lyophilised powder |
| Regulatory Reference | MHRA |
| Shipping | DHL/FedEx temperature-controlled |
| Transit to UK | 5-10 business days |
| Documentation | CoA, HPLC, MS, export docs |
Research Applications of Retatrutide
Retatrutide is used in triple GIP/GLP-1/glucagon receptor research. Research institutions in UK source this compound for preclinical studies under applicable MHRA research regulations.
Why UK Researchers Source Retatrutide from India
- WHO-GMP certified Indian manufacturer — internationally recognised compliance
- Competitive pricing for bulk research quantities
- Full export documentation package for MHRA compliance
- Temperature-controlled DHL/FedEx shipping to UK
- Dedicated international research supply team
- 98%+ purity guaranteed with independent third-party CoA
Related Peptides in UK
Semaglutide in UK | Tirzepatide in UK | Liraglutide in UK | Mazdutide in UK
Retatrutide — Other Countries
Retatrutide in USA | Retatrutide in Germany | Retatrutide in Australia | Retatrutide in Canada
Source from India — Key Manufacturing Cities
Retatrutide in Mumbai, India | Retatrutide in Delhi, India | Retatrutide in Hyderabad, India | Retatrutide in Bangalore, India
Request Retatrutide for your UK research facility: Send your institution details and quantity requirements. We respond within 24 hours with FOB pricing and export documentation.
